We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
AUM
$2.12B
AUM Growth
-$106M
Cap. Flow
-$278M
Cap. Flow %
-13.14%
Top 10 Hldgs %
15.11%
Holding
3,428
New
141
Increased
902
Reduced
1,320
Closed
392
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CENN icon
3001
Cenntro
CENN
$8.51M
$24 ﹤0.01%
+1
New +$111
PXLW icon
3002
Pixelworks
PXLW
$37.2M
$24 ﹤0.01%
2
CELZ icon
3003
Creative Medical Technology
CELZ
$4.78M
$23 ﹤0.01%
5
PSMT icon
3004
Pricesmart
PSMT
$5.9B
-35
Closed -$2.48K
TTOO
3005
DELISTED
T2 Biosystems, Inc
TTOO
$23 ﹤0.01%
107
+106
+10,600% +$810
ICCT
3006
DELISTED
iCoreConnect
ICCT
$20 ﹤0.01%
1
PRPO icon
3007
Precipio
PRPO
$40.5M
$20 ﹤0.01%
+3
New +$21
CRBP icon
3008
Corbus Pharmaceuticals
CRBP
$168M
$18 ﹤0.01%
3
HIPO icon
3009
Hippo Holdings
HIPO
$789M
$18 ﹤0.01%
2
LOGC
3010
DELISTED
ContextLogic
LOGC
$18 ﹤0.01%
3
FTCH
3011
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$16 ﹤0.01%
700
CEI
3012
DELISTED
Camber Energy, Inc
CEI
$16 ﹤0.01%
70
INDV icon
3013
Indivior Pharmaceuticals
INDV
$4.85B
$15 ﹤0.01%
1
NVTA
3014
DELISTED
Invitae Corporation
NVTA
$15 ﹤0.01%
24
BINI
3015
DELISTED
Bollinger Innovations
BINI
0
VERV
3016
DELISTED
Verve Therapeutics
VERV
$14 ﹤0.01%
1
GOEV
3017
DELISTED
Canoo Inc. Class A Common Stock
GOEV
0
RDHL
3018
Redhill Biopharma
RDHL
$4.44M
0
RXRX icon
3019
Recursion Pharmaceuticals
RXRX
$1.62B
$10 ﹤0.01%
1
SDC
3020
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$10 ﹤0.01%
1,600
ALEX
3021
DELISTED
Alexander & Baldwin
ALEX
-151
Closed -$2.55K
RAD
3022
DELISTED
Rite Aid Corporation
RAD
$9 ﹤0.01%
40
YTEN
3023
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$7 ﹤0.01%
1
SOUN icon
3024
SoundHound AI
SOUN
$2.72B
$6 ﹤0.01%
3
-100
-97% -$198
MVIS icon
3025
Microvision
MVIS
$86.6M
$5 ﹤0.01%
2

Similar funds

IFP Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, IFP Advisors held 3,428 positions worth $2.12B, down 4.8% from $2.22B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

IFP Advisors withdrew a net $278M in Q4 2023, closing 392 positions and reducing 1,320 holdings. Its most notable exit was Pacer Aristotle Pacific Floating Rate High Income ETF, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 6.9% a quarter earlier, followed by Financials and Industrials.

Against the trend, IFP Advisors opened a new position in State Street SPDR Portfolio Long Term Corporate Bond ETF worth $2.61M.

  • IFP Advisors's largest Q4 2023 buy was State Street SPDR Portfolio Long Term Corporate Bond ETF: 109,618 shares worth $2.61M.
  • IFP Advisors added most to iShares 20+ Year Treasury Bond ETF in Q4 2023, an estimated $13.4M increase.
  • IFP Advisors's biggest Q4 2023 reduction was WisdomTree Floating Rate Treasury Fund, cutting an estimated $58.6M.
  • IFP Advisors fully exited Pacer Aristotle Pacific Floating Rate High Income ETF in Q4 2023, selling an estimated $10.2M.
  • IFP Advisors's ten largest holdings make up 15% of its $2.12B portfolio in Q4 2023.
  • IFP Advisors opened 141 new positions and closed 392 in Q4 2023.
  • IFP Advisors's portfolio value fell 4.8% quarter-over-quarter to $2.12B.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.